• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    InVivo Therapeutics Holdings Corp. (NVIV)

    -Other OTC
    1.39 Up 0.08(6.11%) Dec 24, 12:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development10,533  6,376  4,103  
    Selling General and Administrative8,472  6,404  4,556  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (19,005) (12,779) (8,659)
    Income from Continuing Operations
    Total Other Income/Expenses Net(19,621)17,515  (26,057)
    Earnings Before Interest And Taxes(38,626)4,735  (34,716)
    Interest Expense130  72  13  
    Income Before Tax(38,756)4,664  (34,728)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(38,756)4,664  (34,728)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (38,756) 4,664   (34,728)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (38,756) 4,664   (34,728)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.